Patient Diagnostic Testing Articles & Analysis
8 news found
“We are excited to work alongside Interpace Diagnostics and Twist Bioscience in providing better solutions in cancer diagnostics for patients and patients’ families,” said Alejandro Tocigl, Miroculus CEO. ...
Related to this new functionality, Bionano is participating as an industry partner with the nonprofit organization Friends of Cancer Research on a research project to harmonize the use of HRD as a biomarker to guide certain treatment types. Diagnostic Laboratory Services (Hawaii) will serve as the collaborator and laboratory testing site, leveraging the HRD ...
–(BUSINESS WIRE)– GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today the upcoming oral presentation of the discovery and initial clinical utility of a novel signature that identifies patients with head and neck squamous cell carcinoma (HNSCC) that may benefit from treatment beyond ...
The primary focus of the investment from the ADDF’s Diagnostics Accelerator is to support the pivotal study for Optina’s awAIr TM cerebral amyloid status test when AD is suspected. ...
The pathology underlying memory loss can begin years before the first symptoms appear. Currently, no single diagnostic test exists for patients who are experiencing symptoms of cognitive decline. ...
Since mesothelioma is challenging to diagnose and patients often have limited treatment options, clinical trials are essential to improving survival and getting closer to finding a cure. ...
The G1A™ test, if administered at $25 to $30 per month, could save $75 to $100 per patient per month in the cost of SMBG test strips. ...
We are using these approaches to provide improved clinical genetic diagnostic testing services for patients with inherited eye disorders." ...